胡健, 黄厚斌, 魏世辉. 羟氯喹性视网膜病变及其检测[J]. 解放军医学院学报, 2014, 35(11): 1171-1174. DOI: 10.3969/j.issn.2095-5227.2014.11.025
引用本文: 胡健, 黄厚斌, 魏世辉. 羟氯喹性视网膜病变及其检测[J]. 解放军医学院学报, 2014, 35(11): 1171-1174. DOI: 10.3969/j.issn.2095-5227.2014.11.025
HU Jian, HUANG Hou-bin, WEI Shi-hui. Hydroxychloroquine retinopathy and its screening test[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2014, 35(11): 1171-1174. DOI: 10.3969/j.issn.2095-5227.2014.11.025
Citation: HU Jian, HUANG Hou-bin, WEI Shi-hui. Hydroxychloroquine retinopathy and its screening test[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2014, 35(11): 1171-1174. DOI: 10.3969/j.issn.2095-5227.2014.11.025

羟氯喹性视网膜病变及其检测

Hydroxychloroquine retinopathy and its screening test

  • 摘要: 羟氯喹在临床上广泛应用于自身免疫性结缔组织病,羟氯喹性视网膜病变发病率低,但视觉损害严重。近年来一些新的技术应用于临床,可以早期发现羟氯喹性视网膜病变。本文仅就羟氯喹性视网膜病变概况和检测方法进展做一简要综述。

     

/

返回文章
返回